- Home
- UAMY vs ABEO Comparison
UAMY vs ABEO Comparison
Compare UAMY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- ABEO
- Stock Information
- Founded
- UAMY 1968
- ABEO 1974
- Country
- UAMY United States
- ABEO United States
- Employees
- UAMY N/A
- ABEO 136
- Industry
- UAMY Metal Fabrications
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- ABEO Health Care
- Exchange
- UAMY Nasdaq
- ABEO Nasdaq
- Market Cap
- UAMY 316.8M
- ABEO 289.2M
- IPO Year
- UAMY N/A
- ABEO 1980
- Fundamental
- Price
- UAMY $5.57
- ABEO $5.64
- Analyst Decision
- UAMY Strong Buy
- ABEO Strong Buy
- Analyst Count
- UAMY 5
- ABEO 6
- Target Price
- UAMY $3.60
- ABEO $18.17
- AVG Volume (30 Days)
- UAMY 5.7M
- ABEO 765.1K
- Earning Date
- UAMY 11-11-2025
- ABEO 11-13-2025
- Dividend Yield
- UAMY N/A
- ABEO N/A
- EPS Growth
- UAMY N/A
- ABEO N/A
- EPS
- UAMY N/A
- ABEO 0.99
- Revenue
- UAMY $25,728,046.00
- ABEO $400,000.00
- Revenue This Year
- UAMY $209.07
- ABEO N/A
- Revenue Next Year
- UAMY $98.95
- ABEO $324.71
- P/E Ratio
- UAMY N/A
- ABEO $5.66
- Revenue Growth
- UAMY 134.91
- ABEO N/A
- 52 Week Low
- UAMY $0.49
- ABEO $3.93
- 52 Week High
- UAMY $5.67
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- UAMY 72.98
- ABEO 30.38
- Support Level
- UAMY $4.46
- ABEO $6.53
- Resistance Level
- UAMY $5.00
- ABEO $6.95
- Average True Range (ATR)
- UAMY 0.37
- ABEO 0.30
- MACD
- UAMY 0.06
- ABEO -0.16
- Stochastic Oscillator
- UAMY 92.86
- ABEO 7.45
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.